We and others reported that use of Kv11.1 blockers or gene suppression produces cytotoxicity in several cancer cells42–45 but the use of Kv11.1 blockers as therapeutic agents is discouraged due to their negative effects on the heart19 (e.g., ventricular fibrillation). Here, KCNH2 is linked to ventricular fibrillation.